Literature DB >> 22231236

JIA in 2011: New takes on categorization and treatment.

Alberto Martini1.   

Abstract

In 2011, new treatment recommendations for juvenile idiopathic arthritis (JIA) were proposed, inroads were made towards understanding the heterogeneity of this disease, and data were presented demonstrating the potential efficacy of DMARD combination therapies for JIA treatment. These advances hold promise for improved management of JIA in 2012 and beyond.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22231236     DOI： 10.1038/nrrheum.2011.198

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

2.  Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis?

Authors:  Alberto Martini
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

3.  Pediatric regulatory initiatives.

Authors:  Steven Hirschfeld; Agnes Saint-Raymond
Journal:  Handb Exp Pharmacol       Date:  2011

4.  Pediatric rheumatology: Strengths and challenges of a new guide for treating JIA.

Authors:  Philip J Hashkes
Journal:  Nat Rev Rheumatol       Date:  2011-05-17       Impact factor: 20.543

5.  Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Authors:  Pirjo Tynjälä; Paula Vähäsalo; Maarit Tarkiainen; Liisa Kröger; Kristiina Aalto; Merja Malin; Anne Putto-Laurila; Visa Honkanen; Pekka Lahdenne
Journal:  Ann Rheum Dis       Date:  2011-05-28       Impact factor: 19.103

Review 6.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

7.  Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Giulia C Varnier; Sheila Oliveira; Esteban Castell; Olga Arguedas; Alessandra Magnani; Angela Pistorio; Nicolino Ruperto; Silvia Magni-Manzoni; Roberta Galasso; Bianca Lattanzi; Sara Dalprà; Antonella Battagliese; Sara Verazza; Maddalena Allegra; Alberto Martini
Journal:  Arthritis Rheum       Date:  2011-01

8.  Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis.

Authors:  Michael G Barnes; Alexei A Grom; Susan D Thompson; Thomas A Griffin; Lorie K Luyrink; Robert A Colbert; David N Glass
Journal:  Arthritis Rheum       Date:  2010-11

Review 9.  Paediatric rheumatology--a global perspective.

Authors:  Sujata Sawhney; Claudia Saad Magalhães
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-04       Impact factor: 4.098

Review 10.  A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Authors:  Margaret H Y Ma; Gabrielle H Kingsley; David L Scott
Journal:  Rheumatology (Oxford)       Date:  2009-11-16       Impact factor: 7.580
  10 in total
  5 in total

Review 1.  Management of juvenile idiopathic arthritis: hitting the target.

Authors:  Claas Hinze; Faekah Gohar; Dirk Foell
Journal:  Nat Rev Rheumatol       Date:  2015-01-06       Impact factor: 20.543

2.  MicroRNA-125b regulates Th17/Treg cell differentiation and is associated with juvenile idiopathic arthritis.

Authors:  Zhi-Dan Fan; Qian Cao; Na Huang; Le Ma; Hui-Hui Ma; Ya-Yuan Zhang; Hai-Guo Yu; Guo-Ping Zhou
Journal:  World J Pediatr       Date:  2019-05-17       Impact factor: 2.764

3.  Fatigue in children with juvenile idiopathic arthritis: reliability of the "Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale".

Authors:  Luciana Tudech S P Paulo; Claudio A Len; Maria Odete E Hilario; Soraya A Pedroso; Maria Sylvia S Vitalle; Maria Teresa Terreri
Journal:  Rheumatol Int       Date:  2014-06-19       Impact factor: 2.631

Review 4.  Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches.

Authors:  Edward J Oberle; Julia G Harris; James W Verbsky
Journal:  Clin Epidemiol       Date:  2014-10-24       Impact factor: 4.790

5.  T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis.

Authors:  Ian D Ferguson; Patricia Griffin; Joshua J Michel; Hiroshi Yano; Sarah L Gaffen; Robert G Mueller; Jeffrey A Dvergsten; Jon D Piganelli; Margalit E Rosenkranz; Daniel A Kietz; Abbe N Vallejo
Journal:  Front Immunol       Date:  2018-08-06       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.